yes all stocks are sensitive to market corrections small biotechs included. Prr was fortunate enough thanks to its hard working management to gain access to funds at a difficult time, which will enable it to proceed even if the market corrects, with its plans in the medium term, and providing positive news is forthcoming in its journey to commercialising Cavc the progress will be reflected in its share price.
But in the mean time D day is approaching for traders........
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.005(1.64%) |
Mkt cap ! $451.2M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.8¢ | 30.0¢ | $293.4K | 952.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2711 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 32143 | 1 |
View Market Depth
| Last trade - 16.10pm 28/02/2025 (20 minute delay) ? |
| IMM (ASX) Chart |